The antibody response plays a key role in protection against viral infections. While antiviral
antibodies may reduce the viral burden via several mechanisms, the ability to directly inhibit …

Zika virus (ZIKV), a mosquito-borne flavivirus with homology to Dengue virus (DENV), has
become a public health emergency. By characterizing memory lymphocytes from ZIKV …

For decades, human infections with Zika virus (ZIKV), a mosquito‐transmitted flavivirus, were
sporadic, associated with mild disease, and went underreported since symptoms were …

Dengue virus, a positive-sense RNA virus, is one of the major human pathogens transmitted
by mosquitoes. However, no fully effective licensed dengue vaccines or therapeutics are …

Dengue viruses (DENV) are mosquito-borne flaviviruses of global importance. DENV exist
as four serotypes, DENV1-DENV4. Following a primary infection, individuals produce DENV …

Several Zika virus (ZIKV) vaccine candidates have recently been described which use
inactivated whole virus, DNA or RNA that express the virus' Envelope (E) glycoprotein as the …

In this study, we described the generation and immunogenicity of the Zika Virus (ZIKV)
envelope protein (E) domain III (DIII) as a protein subunit vaccine candidate. ZIKV EDIII …

Following natural dengue virus (DENV) infection, humans produce some antibodies that
recognize only the serotype of infection (type specific) and others that cross-react with all …

Dengue virus (DENV) is a worldwide health burden, and a safe vaccine is needed.
Neutralizing antibodies bind to quaternary epitopes on DENV envelope (E) protein …

The envelope (E) protein of dengue virus (DENV) is the major target of neutralizing
antibodies (Abs) and vaccine development. Previous studies of human dengue-immune …